Dendritic cell-based therapeutic cancer vaccines: past, present and future

被引：65

作者：

Ahmed, Md Selim ^{[1
]}

Bae, Yong-Soo ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Dept Biol Sci, 2066 Seobu Ro, Suwon 446740, South Korea

来源：

CLINICAL AND EXPERIMENTAL VACCINE RESEARCH | 2014年 / 3卷 / 02期

关键词：

D O I：

10.7774/cevr.2014.3.2.113

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

引用

收藏

页码：113 / 116

页数：4

相关论文

共 11 条

[1]

Dendritic Cell-Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM.CAIX in Immunocompetent Mouse Models [J].

Birkhaeuser, Frederic D. ;

Koya, Richard C. ;

Neufeld, Caleb ;

Rampersaud, Edward N. ;

Lu, Xuyang ;

Micewicz, Ewa D. ;

Chodon, Thinle ;

Atefi, Mohammad ;

Kroeger, Nils ;

Chandramouli, Gadisetti V. R. ;

Li, Gang ;

Said, Jonathan W. ;

McBride, William H. ;

Kabbinavar, Fairooz F. ;

Ribas, Antoni ;

Pantuck, Allan J. ;

Belldegrun, Arie S. ;

Riss, Joseph .

JOURNAL OF IMMUNOTHERAPY, 2013, 36 (02) :102-111

[2]

Dendritic cells in cancer immunotherapy clinical trials: are we making progress? [J].

Butterfield, Lisa H. .

FRONTIERS IN IMMUNOLOGY, 2013, 4

[3]

Dendritic cell immunotherapy: mapping the way [J].

Figdor, CG ;

de Vries, IJM ;

Lesterhuis, WJ ;

Melief, CJM .

NATURE MEDICINE, 2004, 10 (05) :475-480

[4]

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma [J].

Kim, Jung Han ;

Lee, Yoon ;

Bae, Yong-Soo ;

Kim, Won Seog ;

Kim, Kihyun ;

Im, Ho Yeong ;

Kang, Won Ki ;

Park, Keunchil ;

Choi, Han Yong ;

Lee, Hyun Moo ;

Kang, Won Ki ;

Lee, Hyunah ;

Doh, Hyounmie ;

Kim, Byong-Moon ;

Kim, Chae Young ;

Jeon, ChoonJu ;

Jung, Chu Won .

CLINICAL IMMUNOLOGY, 2007, 125 (03) :257-267

[5]

DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors [J].

Lim, Dae-Seog ;

Kim, Jeong-Hwan ;

Lee, Dong-Seong ;

Yoon, Cheol-Hee ;

Bae, Yong-Soo .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (11) :1817-1829

[6]

Egr2 induced during DC development acts as an intrinsic negative regulator of DC immunogenicity [J].

Miah, Mohammad Alam ;

Byeon, Se Eun ;

Ahmed, Md. Selim ;

Yoon, Cheol-Hee ;

Ha, Sang-Jun ;

Bae, Yong-Soo .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (09) :2484-2496

[7]

CISH is induced during DC development and regulates DC-mediated CTL activation [J].

Miah, Mohammad Alam ;

Yoon, Cheol-Hee ;

Kim, Joonoh ;

Jang, Jinah ;

Seong, Young-Rim ;

Bae, Yong-Soo .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (01) :58-68

[8]

Dendritic-Cell-Based Therapeutic Cancer Vaccines [J].

Palucka, Karolina ;

Banchereau, Jacques .

IMMUNITY, 2013, 39 (01) :38-48

[9]

Cancer immunotherapy via dendritic cells [J].

Palucka, Karolina ;

Banchereau, Jacques .

NATURE REVIEWS CANCER, 2012, 12 (04) :265-277

[10]

Decisions About Dendritic Cells: Past, Present, and Future [J].

Steinman, Ralph M. .

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 :1-22